TRAX First Tracks Biotherapeutics, Inc.

CIK 0002091349 4 ready 8-Ks latest June 22, 2026, 4:05 PM ET RSS · JSON

Activity: NORMAL 1 filings / 30d vs 0 baseline

Ready 8-Ks 4

Latest filing June 22, 2026, 4:05 PM ET

Top materiality 0.80

Event mix other_material ×3 · earnings ×1

Sentiment 0 pos · 0 neg · 4 neu

Recent 8-K filings for TRAX

Highest-materiality recent filing

First Tracks Biotherapeutics completes spin-off from AnaptysBio and raises ~$80M in private placement

April 20, 2026, 7:59 PM ET other material materiality 0.80 neutral item 1.01 item 2.01 item 3.02 item 3.03 item 5.03 item 5.01 item 5.02 item 8.01 item 9.01 ◈ Governance Changes ×2◈ Material Agreements ×2◈ Equity Issuances◈ M&A Transactions

Spin-off effective April 20, 2026; AnaptysBio holders received one First Tracks share per AnaptysBio share held on April 6 record date.
Private placement of ~10.5M shares at $13.81: company issued 5.79M shares (~$80M proceeds) and selling stockholder sold 4.71M shares.

June 22, 2026, 4:05 PM ET other material materiality 0.30 neutral item 1.01 ◈ Material Agreements

First Tracks Biotherapeutics subleases 45,057 sq ft San Diego office from AnaptysBio for 12 months

Subleased 45,057 rentable square feet at 10770 Wateridge Circle, San Diego from AnaptysBio, Inc.
May 14, 2026, 4:24 PM ET earnings materiality 0.65 neutral item 2.02 item 9.01 ◈ Earnings Releases

First Tracks Q1 net loss $50.5M; launched with $180M cash; ANB033 Phase 1b data expected Q4 2026

Net loss of $50.5M for Q1 2026 vs $47.2M in Q1 2025; R&D expense $34.0M (down from $41.5M).
April 20, 2026, 7:59 PM ET other material materiality 0.80 neutral item 1.01 item 2.01 item 3.02 item 3.03 item 5.03 item 5.01 item 5.02 item 8.01 item 9.01 ◈ Governance Changes ×2◈ Material Agreements ×2◈ Equity Issuances◈ M&A Transactions

First Tracks Biotherapeutics completes spin-off from AnaptysBio and raises ~$80M in private placement

Spin-off effective April 20, 2026; AnaptysBio holders received one First Tracks share per AnaptysBio share held on April 6 record date.
April 3, 2026, 7:59 PM ET other material materiality 0.80 neutral item 7.01 item 9.01

First Tracks Biotherapeutics spin-off from AnaptysBio effective April 20; $80M PIPE at $13.81/sh

Spin-off of biopharma assets: holders receive 1 share TRAX per ANAB share held on April 6 record date.

Max materiality 0.80 · Median 0.73 · Most common event other_material

0 positive 0 negative 4 neutral